The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

Mucor PCR testing of bronchoalveolar lavage (BAL) fluid showed high specificity in identifying invasive pulmonary mucormycosis (IPM) in lung transplant recipients, especially when used in conjunction ...

“Infectious diseases don’t respect borders,” says Khoa Thai, a clinical microbiologist at the Star-shl medical diagnostics laboratory in the Netherlands. To limit their spread, we need a globally ...

Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...

Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff ...

During the COVID-19 pandemic, a staggering 340 million tests for the virus were supplied across the world by a company based in South Korea that specializes in so-called syndromic real-time polymerase ...